Page last updated: 2024-10-27

furosemide and Hyperparathyroidism, Primary

furosemide has been researched along with Hyperparathyroidism, Primary in 5 studies

Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.

Hyperparathyroidism, Primary: A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.

Research Excerpts

ExcerptRelevanceReference
"In a large longitudinal prospective cohort study of mostly older white women, a history of hypertension and use of furosemide were associated with a significantly higher risk of developing P-HPTH."3.81Hypertension, Antihypertensive Medications, and Risk of Incident Primary Hyperparathyroidism. ( Curhan, GC; Kronenberg, H; Paik, JM; Taylor, EN; Vaidya, A, 2015)
"Primary hyperparathyroidism is caused by an adenoma/hyperplasia in the parathyroid glands in which hypercalcemia is mainly due to an increased secretion of parathormone (PTH)."1.35[Primary hyperparathyroidism. An alternative to the surgery]. ( Alameda Hernando, C; Díaz Guardiola, P; Guijarro de Armas, G; Iglesias Bolaños, P; Pavón de Paz, I; Vega Piñero, B, 2009)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Gücek Haciyanli, S1
Acar, N1
Gür, EÖ1
Çelik, SC1
Karaıslı, S1
Dilek, ON1
Haciyanli, M1
Capozza, M1
Chinellato, I1
Guarnieri, V1
Di Lorgi, N1
Accadia, M1
Traggiai, C1
Mattioli, G1
Di Mauro, A1
Laforgia, N1
Vaidya, A1
Curhan, GC1
Paik, JM1
Kronenberg, H1
Taylor, EN1
Díaz Guardiola, P1
Vega Piñero, B1
Alameda Hernando, C1
Pavón de Paz, I1
Iglesias Bolaños, P1
Guijarro de Armas, G1
Serra Soler, G1
García Fernández, H1
Quevedo Juanals, J1
Argüelles Jiménez, I1
Carrillo García, P1

Other Studies

5 other studies available for furosemide and Hyperparathyroidism, Primary

ArticleYear
Severe hypercalcaemia of primary hyperparathyroidism: Could giant adenoma be the real culprit rather than carcinoma?
    Annals of the Royal College of Surgeons of England, 2020, Volume: 102, Issue:5

    Topics: Adenoma; Adult; Aged; Calcium; Carcinoma; Diphosphonates; Female; Furosemide; Humans; Hypercalcemia;

2020
Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.
    BMC pediatrics, 2018, 10-30, Volume: 18, Issue:1

    Topics: Bone Density Conservation Agents; Calcimimetic Agents; Cinacalcet; Clodronic Acid; Diphosphonates; F

2018
Hypertension, Antihypertensive Medications, and Risk of Incident Primary Hyperparathyroidism.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:6

    Topics: Adult; Antihypertensive Agents; Female; Furosemide; Humans; Hyperparathyroidism, Primary; Hypertensi

2015
[Primary hyperparathyroidism. An alternative to the surgery].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009, Volume: 56, Issue:3

    Topics: Adenoma; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Cinacalcet; Comorbid

2009
[Parathyroid crisis due to a cystic parathyroid adenoma].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:3

    Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Colectomy; Colonic Diseases;

2011